SEC Filing Details

Document Details

Form
Filing Date
08-03-2020
Document Date
08-03-2020
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
Taysha Gene Therapies
Issuer
TAYSHA GENE THERAPIES, INC.
Scroll to top